Cutis marmorata
WikiDoc Resources for Cutis marmorata |
Articles |
---|
Most recent articles on Cutis marmorata Most cited articles on Cutis marmorata |
Media |
Powerpoint slides on Cutis marmorata |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cutis marmorata at Clinical Trials.gov Trial results on Cutis marmorata Clinical Trials on Cutis marmorata at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cutis marmorata NICE Guidance on Cutis marmorata
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cutis marmorata Discussion groups on Cutis marmorata Patient Handouts on Cutis marmorata Directions to Hospitals Treating Cutis marmorata Risk calculators and risk factors for Cutis marmorata
|
Healthcare Provider Resources |
Causes & Risk Factors for Cutis marmorata |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Template:Seealso Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
When a newborn infant is exposed to low environmental temperatures, an evanescent, lacy, reticulated red and/or blue cutaneous vascular pattern appears over most of the body surface. This vascular change represents an accentuated physiologic vasomotor response that disappears with increasing age, although it is sometimes discernible even in older children.
Persistent and pronounced cutis marmorata occurs in Menkes disease, familial dysautonomia, cornelia de Lange, trisomy 13 and trisomy 18 syndromes.
Cutis marmorata telangiectatica congenita is clinically similar, but the lesions are more intense, may be segmental, are persistent, and may be associated with loss of dermal tissue, epidermal atrophy and ulceration.